Skip to content
Disclosery

SILVERARC CAPITAL MANAGEMENT, LLC

Follow

13F filer, CIK 1816307, BOSTON, MA

SILVERARC CAPITAL MANAGEMENT, LLC reported $962,154,050 across 73 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-13. Its ten largest share positions make up 45.32% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001420506-26-001563

Period
2026-06-30
Reported value
$962M
Holdings
73
Top 10 weight
45.32%
New
26
Sold out
26

Part of the filer group SILVERARC CAPITAL MANAGEMENT, LLC

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ASNDnew+206,234$55M
ELVNnew+489,382$24.8M
SGMTnew+2,927,698$22.6M
ORKAadded+201,894$19.2M
DFTXnew+400,000$18.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
KALVexited-2,876,407-$57.9M
NUVLexited-354,914-$36.4M
ASNDexited-124,658-$28.5M
DNTHreduced-264,746-$25.8M
GLUEreduced-893,745-$21.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001420506-26-001563, largest first. % of portfolio is the value over $898,518,708, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 206,234 shares 206,234$55M6.12%newTimeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 88,686 shares; 2025Q4: 375,132 shares; 2026Q1: 357,903 shares; 2026Q2: 500,996 shares 500,996$52.4M5.83%+143,093Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,221,362 shares; 2024Q4: 921,137 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 815,075 shares; 2025Q4: 1,245,254 shares; 2026Q1: 1,314,189 shares; 2026Q2: 1,280,707 shares 1,280,707$49.6M5.52%-33,482Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 901,129 shares; 2024Q4: 1,120,473 shares; 2025Q1: 1,381,158 shares; 2025Q2: 2,022,482 shares; 2025Q3: 1,577,283 shares; 2025Q4: 1,738,821 shares; 2026Q1: 1,503,045 shares; 2026Q2: 1,301,979 shares 1,301,979$47.9M5.33%-201,066Timeline
IMNMIMMUNOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,126,210 shares; 2026Q1: 1,850,278 shares; 2026Q2: 2,017,009 shares 2,017,009$42.7M4.76%+166,731Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 190,334 shares; 2025Q2: 95,806 shares; 2025Q3: 674,966 shares; 2025Q4: 750,136 shares; 2026Q1: 654,746 shares; 2026Q2: 390,000 shares 390,000$38M4.23%-264,746Timeline
RYTMRHYTHM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 255,578 shares; 2024Q4: 273,896 shares; 2025Q1: 337,605 shares; 2025Q2: 400,772 shares; 2025Q3: 369,996 shares; 2025Q4: 135,950 shares; 2026Q1: 306,000 shares; 2026Q2: 311,461 shares 311,461$34.6M3.85%+5,461Timeline
ORKAORUKA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 165,389 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 150,908 shares; 2026Q2: 352,802 shares 352,802$33.6M3.74%+201,894Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 694,942 shares; 2025Q4: 1,029,066 shares; 2026Q1: 2,002,040 shares; 2026Q2: 1,108,295 shares 1,108,295$26.8M2.98%-893,745Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 378,746 shares; 2024Q4: 1,230,400 shares; 2025Q1: 1,309,224 shares; 2025Q2: 402,964 shares; 2025Q3: 463,708 shares; 2025Q4: 642,899 shares; 2026Q1: 888,987 shares; 2026Q2: 1,214,390 shares 1,214,390$26.5M2.95%+325,403Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 10,675 shares; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 489,382 shares 489,382$24.8M2.76%newTimeline
IMVTIMMUNOVANT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: not reported; 2026Q1: 414,236 shares; 2026Q2: 619,096 shares 619,096$23.9M2.65%+204,860Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 6,946,488 shares; 2024Q4: 7,543,901 shares; 2025Q1: 7,367,996 shares; 2025Q2: 2,569,591 shares; 2025Q3: 1,368,075 shares; 2025Q4: 1,317,584 shares; 2026Q1: 1,851,812 shares; 2026Q2: 1,263,026 shares 1,263,026$23.1M2.58%-588,786Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 37,539 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,927,698 shares 2,927,698$22.6M2.52%newTimeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 461,660 shares; 2024Q4: 285,120 shares; 2025Q1: 210,901 shares; 2025Q2: not reported; 2025Q3: 539,704 shares; 2025Q4: 422,193 shares; 2026Q1: 302,530 shares; 2026Q2: 169,593 shares 169,593$22.6M2.52%-132,937Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 67,045 shares; 2024Q4: 72,516 shares; 2025Q1: 166,074 shares; 2025Q2: 10,000 shares; 2025Q3: 51,210 shares; 2025Q4: 82,465 shares; 2026Q1: 71,552 shares; 2026Q2: 65,679 shares 65,679$22M2.45%-5,873Timeline
KODKODIAK SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 500,000 shares; 2024Q4: 1,000,000 shares; 2025Q1: 441,807 shares; 2025Q2: 401,540 shares; 2025Q3: 1,000,000 shares; 2025Q4: 1,023,122 shares; 2026Q1: 991,930 shares; 2026Q2: 546,256 shares 546,256$21.3M2.37%-445,674Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 400,000 shares 400,000$18.8M2.09%newTimeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 470,565 shares; 2024Q4: 503,281 shares; 2025Q1: 633,832 shares; 2025Q2: 448,495 shares; 2025Q3: 235,791 shares; 2025Q4: 357,558 shares; 2026Q1: 179,700 shares; 2026Q2: 318,001 shares 318,001$18.7M2.08%+138,301Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 91,914 shares; 2026Q1: 98,514 shares; 2026Q2: 99,826 shares 99,826$15M1.67%+1,312Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,147,891 shares; 2024Q4: 1,221,131 shares; 2025Q1: 882,300 shares; 2025Q2: not reported; 2025Q3: 1,897,383 shares; 2025Q4: 1,994,224 shares; 2026Q1: 1,911,785 shares; 2026Q2: 3,032,060 shares 3,032,060$14.2M1.58%+1,120,275Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,135,935 shares; 2026Q2: 509,789 shares 509,789$12.9M1.44%-626,146Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 482,575 shares; 2024Q4: 734,234 shares; 2025Q1: 530,000 shares; 2025Q2: 539,587 shares; 2025Q3: 588,789 shares; 2025Q4: 541,240 shares; 2026Q1: 511,127 shares; 2026Q2: 678,095 shares 678,095$12.6M1.41%+166,968Timeline
HLXCHELIX ACQUISITION CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,208,986 shares; 2026Q2: 1,177,821 shares 1,177,821$12.5M1.39%-31,165Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 5,744,757 shares 5,744,757$11.9M1.32%newTimeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 95,000 shares 95,000$11.7M1.3%newTimeline
XENEXENON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,121 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 197,759 shares; 2026Q2: 186,821 shares 186,821$11.3M1.26%-10,938Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 330,487 shares 330,487$10.9M1.21%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 19,940 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 80,419 shares; 2025Q4: 75,412 shares; 2026Q1: 50,967 shares; 2026Q2: 48,101 shares 48,101$10.4M1.16%-2,866Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,946,482 shares 1,946,482$10.3M1.15%newTimeline
CERSCERUS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,495,329 shares; 2024Q4: 1,587,228 shares; 2025Q1: 2,456,537 shares; 2025Q2: 2,488,291 shares; 2025Q3: 2,715,786 shares; 2025Q4: 2,814,383 shares; 2026Q1: 3,176,547 shares; 2026Q2: 3,472,737 shares 3,472,737$10.1M1.13%+296,190Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 720,922 shares; 2025Q4: 524,436 shares; 2026Q1: not reported; 2026Q2: 500,402 shares 500,402$9.25M1.03%newTimeline
BNTCBENITEC BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 250,000 shares; 2025Q2: 253,234 shares; 2025Q3: 276,267 shares; 2025Q4: 731,717 shares; 2026Q1: 717,725 shares; 2026Q2: 679,826 shares 679,826$9.1M1.01%-37,899Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 60,500 shares; 2024Q4: 40,788 shares; 2025Q1: not reported; 2025Q2: 287,796 shares; 2025Q3: 314,339 shares; 2025Q4: 148,787 shares; 2026Q1: 144,981 shares; 2026Q2: 145,000 shares 145,000$8.43M0.94%+19Timeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 122,269 shares 122,269$8.39M0.93%newTimeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,430,982 shares; 2026Q2: 1,355,459 shares 1,355,459$8.35M0.93%-75,523Timeline
OVIDOVID THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 3,101,129 shares 3,101,129$8.34M0.93%+2,101,129Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,099,490 shares; 2024Q4: 1,178,300 shares; 2025Q1: 2,060,240 shares; 2025Q2: 1,800,829 shares; 2025Q3: 1,948,808 shares; 2025Q4: 1,116,604 shares; 2026Q1: 1,100,010 shares; 2026Q2: 738,873 shares 738,873$8M0.89%-361,137Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 300,000 shares; 2026Q2: 503,382 shares 503,382$7.12M0.79%+203,382Timeline
CGENCOMPUGEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,501,113 shares; 2024Q4: 1,624,377 shares; 2025Q1: 2,895,430 shares; 2025Q2: 3,033,879 shares; 2025Q3: 3,311,165 shares; 2025Q4: 3,479,805 shares; 2026Q1: 3,315,845 shares; 2026Q2: 3,184,257 shares 3,184,257$6.81M0.76%-131,588Timeline
SLDBSOLID BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 457,739 shares; 2024Q4: not reported; 2025Q1: 452,239 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 668,450 shares 668,450$6.68M0.74%newTimeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 106,000 shares; 2026Q1: 226,000 shares; 2026Q2: 3,520,490 shares 3,520,490$6.16M0.69%+3,294,490Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 103,862 shares; 2024Q4: 110,381 shares; 2025Q1: 236,471 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 196,028 shares; 2026Q2: 82,800 shares 82,800$6.06M0.67%-113,228Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 124,871 shares; 2025Q2: not reported; 2025Q3: 180,513 shares; 2025Q4: not reported; 2026Q1: 460,314 shares; 2026Q2: 113,494 shares 113,494$5.95M0.66%-346,820Timeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 187,737 shares; 2026Q1: 186,618 shares; 2026Q2: 59,959 shares 59,959$5.32M0.59%-126,659Timeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 525,000 shares 525,000$5.09M0.57%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 166,161 shares; 2025Q4: 307,540 shares; 2026Q1: 301,729 shares; 2026Q2: 296,135 shares 296,135$4.85M0.54%-5,594Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: 100,000 shares; 2025Q1: 203,400 shares; 2025Q2: 202,565 shares; 2025Q3: 455,000 shares; 2025Q4: 126,047 shares; 2026Q1: not reported; 2026Q2: 105,000 shares 105,000$4.84M0.54%newTimeline
RACCRESEARCH ALLIANCE CORP IIIQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 360,000 shares 360,000$3.85M0.43%newTimeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 917,898 shares; 2025Q3: 994,754 shares; 2025Q4: 627,738 shares; 2026Q1: 648,942 shares; 2026Q2: 610,407 shares 610,407$3.77M0.42%-38,535Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 347,695 shares; 2024Q4: 372,230 shares; 2025Q1: 321,366 shares; 2025Q2: 249,060 shares; 2025Q3: 206,648 shares; 2025Q4: 71,256 shares; 2026Q1: 35,850 shares; 2026Q2: 34,438 shares 34,438$3.67M0.41%-1,412Timeline
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 297,460 shares 297,460$2.91M0.32%newTimeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 653,594 shares; 2025Q4: not reported; 2026Q1: 653,594 shares; 2026Q2: 653,594 shares 653,594$2.86M0.32%0Timeline
ELUTELUTIA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,645,808 shares; 2024Q4: 1,782,271 shares; 2025Q1: 2,670,056 shares; 2025Q2: 2,761,684 shares; 2025Q3: 2,850,987 shares; 2025Q4: 2,751,314 shares; 2026Q1: 2,498,020 shares; 2026Q2: 2,192,980 shares 2,192,980$2.15M0.24%-305,040Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 10,000 shares 10,000$1.87M0.21%newTimeline
SIONSIONNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 114,138 shares; 2025Q2: 186,015 shares; 2025Q3: 108,801 shares; 2025Q4: 41,460 shares; 2026Q1: 39,417 shares; 2026Q2: 42,478 shares 42,478$1.87M0.21%+3,061Timeline
TELATELA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 1,124,928 shares; 2024Q4: 3,065,649 shares; 2025Q1: 2,771,288 shares; 2025Q2: 2,779,795 shares; 2025Q3: 2,782,923 shares; 2025Q4: 2,647,512 shares; 2026Q1: 2,259,312 shares; 2026Q2: 2,137,201 shares 2,137,201$1.6M0.18%-122,111Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 227,178 shares 227,178$1.48M0.17%newTimeline
GUTSFRACTYL HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 166,666 shares; 2024Q4: 176,922 shares; 2025Q1: 237,448 shares; 2025Q2: 202,590 shares; 2025Q3: 10,600,000 shares; 2025Q4: 9,840,041 shares; 2026Q1: 1,701,625 shares; 2026Q2: 1,637,976 shares 1,637,976$1.3M0.14%-63,649Timeline
CNTBCONNECT BIOPHARMA HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 545,000 shares 545,000$1.3M0.14%newTimeline
CBIOCRESCENT BIOPHARMA INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 130,500 shares; 2026Q2: 59,104 shares 59,104$1.06M0.12%-71,396Timeline
CLRBCELLECTAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 321,728 shares 321,728$894K0.1%newTimeline
FHTXFOGHORN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 45,975 shares 45,975$224K0.02%newTimeline
ADGMADAGIO MED HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 515,384 shares; 2026Q1: 251,972 shares; 2026Q2: 224,360 shares 224,360$146K0.02%-27,612Timeline
RCKTWROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 104,828 shares; 2024Q4: 104,828 shares; 2025Q1: 104,828 shares; 2025Q2: 104,828 shares; 2025Q3: 104,828 shares; 2025Q4: 104,828 shares; 2026Q1: 104,828 shares; 2026Q2: 104,828 shares 104,828$356<0.01%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
ARK ETF TRARK ETF TR GENOMIC REV ETFput500,000$21Mnew
SYNDAX PHARMACEUTICALS INCSYNDAX PHARMACEUTICALS INC COMcall693,600$15.2M+373,600
ORIC PHARMACEUTICALS INCORIC PHARMACEUTICALS INC CALLcall682,600$7.39Mnew
MONTE ROSA THERAPEUTICS INCMONTE ROSA THERAPEUTICS INC COMcall300,000$7.26Mnew
ABIVAX SAABIVAX SA CALLcall50,000$6.66Mnew
KYMERA THERAPEUTICS INCKYMERA THERAPEUTICS INC PUTput25,000$2.87Mnew
ABSCI CORPORATIONABSCI CORPORATION COMput157,600$1.83Mnew
FULCRUM THERAPEUTICS INCFULCRUM THERAPEUTICS INC COMcall391,900$1.43M0

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SPDR SERIES TRUSTSPDR SERIES TRUST825,000$105Mput
KALVKALVISTA PHARMACEUTICALS INC2,876,407$57.9Mshares
NUVLNUVALENT INC354,914$36.4Mshares
ASNDASCENDIS PHARMA A/S124,658$28.5Mshares
CNTACENTESSA PHARMACEUTICALS PLC466,345$18.5Mshares
SRRKSCHOLAR ROCK HLDG CORP339,613$16.7Mshares
CGONCG ONCOLOGY INC166,349$11.3Mshares
UNIQURE NVUNIQURE NV500,000$8.18Mcall
CELCUITY INCCELCUITY INC54,500$6.22Mcall
CLDXCELLDEX THERAPEUTICS INC NEW178,378$5.66Mshares
CYTKCYTOKINETICS INC71,203$4.69Mshares
CLYMCLIMB BIO INC684,908$4.69Mshares
CMPXCOMPASS THERAPEUTICS INC859,049$4.54Mshares
SRZNSURROZEN INC144,255$4.2Mshares
ZURAZURA BIO LTD560,651$3.34Mshares
FULCFULCRUM THERAPEUTICS INC419,949$3.22Mshares
ANNXANNEXON INC496,461$2.75Mshares
MNPRMONOPAR THERAPEUTICS INC43,488$2.38Mshares
NXTCNEXTCURE INC176,057$1.88Mshares
NMRANEUMORA THERAPEUTICS INC.818,156$1.6Mshares
EWTXEDGEWISE THERAPEUTICS INC42,615$1.34Mshares
REPLREPLIMUNE GROUP INC171,936$1.32Mshares
GENBGENERATE BIOMEDICINES INC100,000$1.25Mshares
COMPASS THERAPEUTICS INCCOMPASS THERAPEUTICS INC172,400$912Kcall
RADXRADIOPHARM THERANOSTICS LTD187,406$806Kshares
AARDAARDVARK THERAPEUTICS INC33,684$127Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001420506-26-001563 base2026-08-13acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001420506-26-001563 Quarter ended 2026-06-302026-08-13acceptance time not in the bulk data set
13F-HR 0001420506-26-001011 Quarter ended 2026-03-312026-05-14acceptance time not in the bulk data set
13F-HR 0001420506-26-000321 Quarter ended 2025-12-312026-02-12acceptance time not in the bulk data set
13F-HR 0001420506-25-003142 Quarter ended 2025-09-302025-11-12acceptance time not in the bulk data set
13F-HR 0001420506-25-002146 Quarter ended 2025-06-302025-08-14acceptance time not in the bulk data set
13F-HR 0001420506-25-001107 Quarter ended 2025-03-312025-05-14acceptance time not in the bulk data set
13F-HR 0001420506-25-000497 Quarter ended 2024-12-312025-02-14acceptance time not in the bulk data set
13F-HR 0001420506-24-002416 Quarter ended 2024-09-302024-11-14acceptance time not in the bulk data set
13F-HR 0001420506-24-001528 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001420506-24-000871 Quarter ended 2024-03-312024-05-15acceptance time not in the bulk data set
13F-HR 0001420506-24-000388 Quarter ended 2023-12-312024-02-14acceptance time not in the bulk data set
13F-HR 0001420506-23-001985 Quarter ended 2023-09-302023-11-13acceptance time not in the bulk data set
13F-HR 0001420506-23-001582 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001420506-23-001081 Quarter ended 2023-03-312023-05-15acceptance time not in the bulk data set
13F-HR 0001420506-23-000635 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001420506-22-001926 Quarter ended 2022-09-302022-10-28acceptance time not in the bulk data set
13F-HR 0001420506-22-001285 Quarter ended 2022-06-302022-07-25acceptance time not in the bulk data set
13F-HR 0001420506-22-000940 Quarter ended 2022-03-312022-05-13acceptance time not in the bulk data set
13F-HR 0001420506-22-000341 Quarter ended 2021-12-312022-02-14acceptance time not in the bulk data set
13F-HR 0001420506-21-001696 Quarter ended 2021-09-302021-11-15acceptance time not in the bulk data set
13F-HR 0001420506-21-001278 Quarter ended 2021-06-302021-08-16acceptance time not in the bulk data set
13F-HR 0001420506-21-000796 Quarter ended 2021-03-312021-05-18acceptance time not in the bulk data set
13F-HR 0001420506-21-000331 Quarter ended 2020-12-312021-02-16acceptance time not in the bulk data set